SCOPUS 정보 검색 플랫폼

British Journal of Ophthalmology

Volumn 93, Issue 8, 2009, Pages 1105-1108

Use of combination therapy with cisplatin and calcitriol in the treatment of Y-79 human retinoblastoma xenograft model

(5) Kulkarni, A D a Van Ginkel, P R a Darjatmoko, S R a Lindstrom, M J a Albert, D M a

a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM BLOOD LEVEL; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RETINOBLASTOMA; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CALCITRIOL; CALCIUM; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MICE; MICE, NUDE; RETINAL NEOPLASMS; RETINOBLASTOMA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 68049092791 PISSN: 00071161 EISSN: 14682079 Source Type: Journal
DOI: 10.1136/bjo.2008.152843 Document Type: Article

Times cited : (19)

References (22)

1
- 0036397635
- Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture
- Albert DM, Nickells RW, Gamm DM, et al. Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture. Ophthalmic Genet 2002;23:137-156
- (2002) Ophthalmic Genet , vol.23 , pp. 137-156
- Albert, D.M.¹ Nickells, R.W.² Gamm, D.M.³

2
- 0141653774
- Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma
- DOI 10.1167/iovs.02-1198
- Audo I, Darjatmoko SR, Schlamp CL, et al. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci 2003;44:4192-4199 (Pubitemid 37186250)
- (2003) Investigative Ophthalmology and Visual Science , vol.44 , Issue.10 , pp. 4192-4199
- Audo, I.¹ Darjatmoko, S.R.² Schlamp, C.L.³ Lokken, J.M.⁴ Lindstrom, M.J.⁵ Albert, D.M.⁶ Nickells, R.W.⁷

3
- 0028796340
- Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma
- Shokravi MT, Marcus DM, Alroy J, et al. Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci 1995;36:83-87
- (1995) Invest Ophthalmol Vis Sci , vol.36 , pp. 83-87
- Shokravi, M.T.¹ Marcus, D.M.² Alroy, J.³

4
- 0033625006
- 3 in murine lymphoma
- DOI 10.1016/S0304-3835(99)00327-4, PII S0304383599003274
- Sarkar A, Saha K, Basak R, et al. Anticlastogenic potential of 1alpha,25- dihydroxyvitamin D3 in murine lymphoma. Cancer Lett 2000;150:1-13. (Pubitemid 30123042)
- (2000) Cancer Letters , vol.150 , Issue.1 , pp. 1-13
- Sarkar, A.¹ Saha, B.K.² Basak, R.³ Mukhopadhyay, I.⁴ Karmakar, R.⁵ Chatterjee, M.⁶

5
- 33748029123
- Mortality from second tumour among long-term survivors of retinoblastoma: A retrospective analysis of the Italian retinoblastoma registry
- DOI 10.1038/sj.onc.1209786, PII 1209786
- Acquaviva A, Ciccolallo L, Rondelli R, et al. Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registry. Oncogene 2006;25:5350-5357 (Pubitemid 44299097)
- (2006) Oncogene , vol.25 , Issue.38 , pp. 5350-5357
- Acquaviva, A.¹ Ciccolallo, L.² Rondelli, R.³ Balistreri, A.⁴ Ancarola, R.⁵ Cozza, R.⁶ Hadjistilianou, D.⁷ Francesco, S.D.⁸ Toti, P.⁹ Pastore, G.¹⁰ Haupt, R.¹¹ Carli, M.¹² Santoro, N.¹³ Cataldo, A.D.¹⁴ Fiorillo, A.¹⁵ Indolfi, P.¹⁶ Nucci, P.¹⁷ Sandri, A.¹⁸ Porta, F.¹⁹ Porcaro, A.B.²⁰ Tamaro, P.²¹ Morgese, G.²² more..

6
- 4444247718
- Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models
- DOI 10.1001/archopht.122.9.1357
- Albert DM, Kumar A, Strugnell SA, et al. Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models. Arch Ophthalmol 2004;122:1357-1362 (Pubitemid 39180858)
- (2004) Archives of Ophthalmology , vol.122 , Issue.9 , pp. 1357-1362
- Albert, D.M.¹ Kumar, A.² Strugnell, S.A.³ Darjatmoko, S.R.⁴ Lokken, J.M.⁵ Lindstrom, M.J.⁶ Patel, S.⁷

7
- 0036252710
- Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model
- Grostern RJ, Bryar PJ, Zimbrick ML, et al. Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model. Arch Ophthalmol 2002;120:607-612
- (2002) Arch Ophthalmol , vol.120 , pp. 607-612
- Grostern, R.J.¹ Bryar, P.J.² Zimbrick, M.L.³

8
- 0037397163
- 2 in LH-β-Tag transgenic mice
- DOI 10.1016/S0161-6420(02)01934-6
- Dawson DJ, Gleiser J, Zimbric ML, et al. Toxicity and dose-response studies of 1- alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice. Ophthalmology 2003;110:835-839 (Pubitemid 36520089)
- (2003) Ophthalmology , vol.110 , Issue.4 , pp. 835-839
- Dawson, D.G.¹ Gleiser, J.² Zimbric, M.L.³ Darjatmoko, S.R.⁴ Lindstrom, M.J.⁵ Strugnell, S.A.⁶ Albert, D.M.⁷

9
- 1842683901
- Results of treatment of retinoblastoma that has infiltrated the optic nerve, is recurrent, or has metastasized outside the eyeball
- DOI 10.1007/s10147-003-0364-2
- Makimoto A. Results of treatment of retinoblastoma that has infiltrated the optic nerve, is recurrent, or has metastasized outside the eyeball. Int J Clin Oncol 2004;9:7-12. (Pubitemid 38470657)
- (2004) International Journal of Clinical Oncology , vol.9 , Issue.1 , pp. 7-12
- Makimoto, A.¹

10
- 0345256652
- Cisplatin: Mode of cytotoxic action and molecular basis of resistance
- Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003;22:7265-7279
- (2003) Oncogene , vol.22 , pp. 7265-7279
- Siddik, Z.H.¹

11
- 24944546758
- Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells
- DOI 10.1002/em.20138
- Silva MJ, Costa P, Dias A, et al. Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells. Environ Mol Mutagen 2005;46:104-115 (Pubitemid 41306636)
- (2005) Environmental and Molecular Mutagenesis , vol.46 , Issue.2 , pp. 104-115
- Silva, M.J.¹ Costa, P.² Dias, A.³ Valente, M.⁴ Louro, H.⁵ Boavida, M.G.⁶

12
- 0026528519
- Is cisplatin a human carcinogen?
- Greene MH. Is cisplatin a human carcinogen? J Natl Cancer Inst 1992;84:306-312
- (1992) J Natl Cancer Inst , vol.84 , pp. 306-312
- Greene, M.H.¹

13
- 34547891848
- Cisplatin nephrotoxicity: A review
- Yao X, Panichpisal K, Kurtzman N, et al. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007;334:115-124
- (2007) Am J Med Sci , vol.334 , pp. 115-124
- Yao, X.¹ Panichpisal, K.² Kurtzman, N.³

14
- 0016237918
- Characteristics of an established cell line of retinoblastoma
- Reid TW, Albert DM, Rabson AS, et al. Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst 1974;53:347-360
- (1974) J Natl Cancer Inst , vol.53 , pp. 347-360
- Reid, T.W.¹ Albert, D.M.² Rabson, A.S.³

15
- 36049037186
- Current treatment and management of retinoblastoma
- Gombos DS, Chevez-Barrios AP. Current treatment and management of retinoblastoma. Curr Oncol Rep 2007;9:453-458
- (2007) Curr Oncol Rep , vol.9 , pp. 453-458
- Gombos, D.S.¹ Chevez-Barrios, A.P.²

16
- 33747890610
- Metastatic Retinoblastoma. Clinical Features, Treatment, and Prognosis
- DOI 10.1016/j.ophtha.2006.03.039, PII S0161642006004520
- Gunduz K, Müftüoglu O, Günalp I, et al. Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology 2006;113:1558-1566 (Pubitemid 44292302)
- (2006) Ophthalmology , vol.113 , Issue.9 , pp. 1558-1566
- Gunduz, K.¹ Muftuoglu, O.² Gunalp, I.³ Unal, E.⁴ Tacyildiz, N.⁵

17
- 36148972070
- Retinoblastoma: Review of current management
- Chintagumpala M, Chevez-Barrios P, Paysse EA, et al. Retinoblastoma: review of current management. Oncologist 2007;12:1237-1246
- (2007) Oncologist , vol.12 , pp. 1237-1246
- Chintagumpala, M.¹ Chevez-Barrios, P.² Paysse, E.A.³

18
- 0032142723
- Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy
- DOI 10.1016/S0002-9394(98)00146-9, PII S0002939498001469
- Mohney BG, Robertson DM, Schomberg PJ, et al. Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy. Am J Ophthalmol 1998;126:269-277 (Pubitemid 28397100)
- (1998) American Journal of Ophthalmology , vol.126 , Issue.2 , pp. 269-277
- Mohney, B.G.¹ Robertson, D.M.² Schomberg, P.J.³ Hodge, D.O.⁴

19
- 1542318327
- Lifetime risks of common cancers among retinoblastoma survivors
- Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004;96:357-363 (Pubitemid 38401013)
- (2004) Journal of the National Cancer Institute , vol.96 , Issue.5 , pp. 357-363
- Fletcher, O.¹ Easton, D.² Anderson, K.³ Gilham, C.⁴ Jay, M.⁵ Peto, J.⁶

20
- 3843124553
- Nonocular second primary tumors after retinoblastoma: Retrospective study of 111 patients treated by electron beam radiotherapy with or without TEM
- DOI 10.1097/01.coc.0000128861.46357.ee
- Schlienger P, Campana F, Vilcoq JR, et al. Nonocular second primary tumors after retinoblastoma: retrospective study of 111 patients treated by electron beam radiotherapy with or without TEM. Am J Clin Oncol 2004;27:411-419 (Pubitemid 39045255)
- (2004) American Journal of Clinical Oncology: Cancer Clinical Trials , vol.27 , Issue.4 , pp. 411-419
- Schlienger, P.¹ Campana, F.² Vilcoq, J.R.³ Asselain, B.⁴ Dendale, R.⁵ Desjardins, L.⁶ Dorval, T.⁷ Quintana, E.⁸ Rodriguez, J.⁹

21
- 27544478276
- Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor vitamin D analog
- Albert DM, Plum LA, Yang W, et al. Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor vitamin D analog. J Steroid Biochem Mol Biol 2005;97:165-172
- (2005) J Steroid Biochem Mol Biol , vol.97 , pp. 165-172
- Albert, D.M.¹ Plum, L.A.² Yang, W.³

22
- 0036689119
- 3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression
- 3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. Mol Cancer Ther 2002;1:821-829
- (2002) Mol Cancer Ther , vol.1 , pp. 821-829
- Hershberger, P.A.¹ McGuire, T.F.² Yu, W.D.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.